Pharmaron Beijing Co Ltd (300759) — Cash Flow Quality Index
Pharmaron Beijing Co Ltd (300759) has a Cash Flow Quality Index of 2.36x as of September 2025. Operating cash flow of CN¥1.04 Billion exceeds net income of CN¥439.52 Million, indicating high earnings quality where cash backs reported profits. Also explore Pharmaron Beijing Co Ltd (300759) total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Pharmaron Beijing Co Ltd Cash Flow Quality Index (2014–2024)
Historical Cash Flow Quality Index for Pharmaron Beijing Co Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Pharmaron Beijing Co Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Pharmaron Beijing Co Ltd (2014–2024)
Year-by-year earnings quality comparison for Pharmaron Beijing Co Ltd. For live market cap and the full company financial profile, see Pharmaron Beijing Co Ltd market cap and net worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.50x | CN¥2.58 Billion | CN¥1.71 Billion | ▼ -12.6% |
| 2023 | 1.72x | CN¥2.75 Billion | CN¥1.60 Billion | ▲ +8.5% |
| 2022 | 1.58x | CN¥2.14 Billion | CN¥1.35 Billion | ▲ +24.8% |
| 2021 | 1.27x | CN¥2.06 Billion | CN¥1.62 Billion | ▼ -11.6% |
| 2020 | 1.44x | CN¥1.65 Billion | CN¥1.15 Billion | ▼ -18.7% |
| 2019 | 1.77x | CN¥938.59 Million | CN¥530.67 Million | ▼ -18.7% |
| 2018 | 2.17x | CN¥737.26 Million | CN¥339.03 Million | ▼ -10.6% |
| 2017 | 2.43x | CN¥552.22 Million | CN¥227.02 Million | ▲ +82.5% |
| 2016 | 1.33x | CN¥235.77 Million | CN¥176.91 Million | ▼ -54.6% |
| 2015 | 2.94x | CN¥216.94 Million | CN¥73.85 Million | ▲ +408.3% |
| 2014 | 0.58x | CN¥12.13 Million | CN¥21.00 Million | — |